Back to mobile site

William Blair Reiterates Outperform Rating on Amgen (AMGN)

November 4, 2026 3:59 AM EST Send to a Friend
William Blair analyst Matt Phipps reiterated an Outperform rating on Amgen (NASDAQ: AMGN).The analyst comments "Stock Thoughts: Amgen shares are ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login